-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Aerovate Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2021 to Q1 2025.
- Aerovate Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2025 was $12.9M, a 45.5% increase year-over-year.
- Aerovate Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the twelve months ending March 31, 2025 was $60M.
- Aerovate Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $56M, a 372% increase from 2023.
- Aerovate Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $11.9M, a 71.5% increase from 2022.
- Aerovate Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $6.93M.
Net Cash Provided by (Used in) Investing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)